Marjolein Geurts

Marjolein Geurts is a researcher in the Department of Neurology at Erasmus MC, focusing on neuro-oncology and brain tumor research. Her work spans clinical, translational, and diagnostic domains, with a focus on glioblastoma, astrocytoma, and molecular profiling of CNS tumors.

Her research interests include tumor immunology, diagnostic imaging (particularly FET PET), chemotherapy optimization (e.g., temozolomide), and evidence-based neuro-oncology. She contributes to clinical trial design and international guideline development, notably with the EORTC and EANO.

The most recent articles show a strong trend toward integrating molecular diagnostics with clinical management, improving accuracy in distinguishing pseudoprogression from true progression, and understanding the tumor microenvironment’s role in immune evasion.

She has no listed scientific awards in the provided text.

Marjolein Geurts collaborates extensively with national and international research groups and participates in multi-center clinical trials and consortium-based guideline development. While no formal advisees are listed, her collaborative work suggests involvement in training and mentoring within research teams.

She is involved in key research initiatives such as the FET POPPING clinical trial and contributes to the EORTC Brain Tumor Group and EANO guideline committees, indicating active participation in structured research networks and clinical innovation.